tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
Advertisement

Citius Pharmaceuticals (CTXR) Ratios

Compare
1,746 Followers

Citius Pharmaceuticals Ratios

CTXR's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, CTXR's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.47 5.95 9.84 18.28 3.41
Quick Ratio
0.14 5.95 9.84 18.28 3.41
Cash Ratio
0.12 4.58 9.21 17.60 3.38
Solvency Ratio
-0.68 -2.66 -3.16 -2.38 -1.73
Operating Cash Flow Ratio
-0.45 -5.03 -6.26 -6.09 -4.13
Short-Term Operating Cash Flow Coverage
-205.29 0.00 -143.97 -136.82 -51.00
Net Current Asset Value
$ -35.50M$ 22.19M$ 33.99M$ 63.17M$ 3.88M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.03
Debt-to-Equity Ratio
0.01 <0.01 <0.01 <0.01 0.04
Debt-to-Capital Ratio
0.01 <0.01 <0.01 <0.01 0.04
Long-Term Debt-to-Capital Ratio
0.01 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
1.96 1.14 1.11 1.08 1.30
Debt Service Coverage Ratio
575.14 0.00 -74.63 -122.02 -50.36
Interest Coverage Ratio
187.80 0.00 -132.52 -2.17K -1.13K
Debt to Market Cap
0.06 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.06 <0.01 <0.01 <0.01 0.03
Net Debt to EBITDA
0.16 0.71 1.25 3.03 0.72
Profitability Margins
Gross Profit Margin
-71.09%0.00%0.00%0.00%0.00%
EBIT Margin
-20738.91%0.00%0.00%0.00%0.00%
EBITDA Margin
-20633.39%0.00%0.00%0.00%0.00%
Operating Profit Margin
-20747.51%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-26382.43%0.00%0.00%0.00%0.00%
Net Profit Margin
-26470.11%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-21080.46%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.33%101.80%101.74%100.31%100.72%
EBT Per EBIT
127.16%87.03%99.25%97.97%99.08%
Return on Assets (ROA)
-32.33%-31.41%-29.51%-16.24%-40.38%
Return on Equity (ROE)
-63.21%-35.83%-32.72%-17.49%-52.49%
Return on Capital Employed (ROCE)
-42.66%-37.55%-30.43%-17.00%-44.64%
Return on Invested Capital (ROIC)
-43.57%-38.14%-30.85%-17.01%-44.41%
Return on Tangible Assets
-34.88%-93.34%-74.34%-31.39%-117.62%
Earnings Yield
-292.95%-1.30%-0.76%-0.42%-1.74%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.03 0.07 0.15 0.13 0.08
Inventory Turnover
0.02 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.18 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
>-0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
9.73K -5.50K -2.37K -2.83K -4.45K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
23.55K 0.00 0.00 0.00 0.00
Days of Payables Outstanding
13.81K 5.50K 2.37K 2.83K 4.45K
Operating Cycle
23.55K 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-2.14 -0.20 -0.19 -0.22 -0.43
Free Cash Flow Per Share
-2.14 -0.20 -0.19 -0.59 -0.43
CapEx Per Share
<0.01 <0.01 0.00 0.37 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 2.65 1.00
Dividend Paid and CapEx Coverage Ratio
-2.94M -14.53M 0.00 -0.61 -9.25K
Capital Expenditure Coverage Ratio
-2.94M -14.53M 0.00 -0.61 -9.25K
Operating Cash Flow Coverage Ratio
-26.71 -60.39 -41.82 -28.35 -12.52
Operating Cash Flow to Sales Ratio
-151.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-164.61%-1.16%-0.64%-1.17%-1.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.34 -76.83 -131.36 -238.33 -57.62
Price-to-Sales (P/S) Ratio
91.73 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
0.22 27.53 42.98 41.70 30.24
Price-to-Free Cash Flow (P/FCF) Ratio
-0.61 -86.04 -155.81 -85.77 -60.14
Price-to-Operating Cash Flow Ratio
-0.60 -86.04 -155.81 -227.27 -60.15
Price-to-Earnings Growth (PEG) Ratio
0.01 17.67 -13.79 4.47 1.39
Price-to-Fair Value
0.22 27.53 42.98 41.70 30.24
Enterprise Value Multiple
-0.28 -67.36 -133.13 -237.87 -57.87
Enterprise Value
9.10M 2.47B 4.38B 5.44B 1.01B
EV to EBITDA
-0.28 -67.36 -133.13 -237.87 -57.87
EV to Sales
58.33 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-0.39 -85.14 -154.36 -84.69 -59.40
EV to Operating Cash Flow
-0.39 -85.14 -154.36 -224.42 -59.41
Tangible Book Value Per Share
5.29 0.16 0.24 0.59 0.13
Shareholders’ Equity Per Share
5.91 0.62 0.70 1.22 0.86
Tax and Other Ratios
Effective Tax Rate
-0.02 -0.02 -0.02 >-0.01 >-0.01
Revenue Per Share
0.01 0.00 0.00 0.00 0.00
Net Income Per Share
-3.75 -0.22 -0.23 -0.21 -0.45
Tax Burden
1.00 1.02 1.02 1.00 1.01
Interest Burden
1.27 0.87 1.00 1.00 1.00
Research & Development to Revenue
66.89 0.00 0.00 0.00 0.00
SG&A to Revenue
145.98 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
70.10 0.00 0.00 0.00 0.00
Income Quality
0.54 0.89 0.84 1.05 0.96
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis